Purdue Loses Case To Stop Generic OxyContin

By Andrew Karpan · April 11, 2023, 10:27 PM EDT

The bankrupt Purdue Pharma lost its legal effort to use patent laws to block an Indian drugmaker from launching a generic version of OxyContin when a federal judge in Delaware decided...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Purdue Pharma L.P. et al v. Accord Healthcare Inc.

Case Number

1:20-cv-01362

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

October 08, 2020